The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a.

20 April 2018 (18:20 - 18:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Gian Felice De Nicola

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

The gut hormone ghrelin in the modulation of cardiac metabolism and vascular resistance

Professor F. Recchia (Pisa, IT)

Presentation thumbnail

Targeting inflammation for cardioprotection.

Professor S. Lecour (Cape Town, ZA)

Presentation thumbnail

Multi-omics strategies for unbiased identification of novel therapeutic targets for cardioprotection.

Professor P. Ferdinandy (Budapest, HU)

Presentation thumbnail

Proteomics of cardioprotection.

Professor M. Mayr (London, GB)

Presentation thumbnail

Cardiac-specific overexpression of the transcription factor JunD promotes increased sensitivity to myocardial infarction

Doctor A. Akhmedov (Zurich, CH)

Abstract Slides

Access the full session

Session thumbnail

New strategies for cardioprotection to prevent heart failure

The Event

Frontiers in CardioVascular Biology 2018

20 April 2018 18:20 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources